HETLIOZ LQ FDA approval date

The FDA approved HETLIOZ LQ on 1 Dec 2020.

FDA approval date
1 Dec 2020

Drug identity has not yet been verified against registry records

Also recorded as TASIMELTEON

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-12-01DayHETLIOZ LQFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214517", "applicant_as_listed_by_fda": "VANDA PHARMS INC", "brand_names": ["HETLIOZ LQ"], "active_ingredients": ["TASIMELTEON"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20201201", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026